Ascend Biopharmaceuticals Ltd
Level 1, 159 Dorcas Street
Ascend is a cancer immunotherapy company developing medicines to treat primary, recurrent and metastatic cancers. Cancers are made up of many different cell types that can influence and regulate the local tumour microenvironment to promote tumour growth. Ascend’s strategy focuses on targeting these key cells and altering the host microenvironment from one that supports tumour growth to one that results in cancer eradication.
CEO: Clement Leong
CMO: Paul Weiden
Please click here for clinical trial information.